Hackensack Meridian launches trial of canine-powered cancer detection

Hackensack Meridian Health launched a clinical trial with Israeli startup SpotitEarly, which is developing a cancer test that combines AI with trained dogs to analyze patients' breath. The study aims to validate this noninvasive approach alongside traditional screenings, potentially enabling earlier and more accessible cancer detection.

Editor's Pick

Top Story Hackensack Meridian Health Launches Trial of Canine-Powered Cancer Detection Hackensack Meridian Health launched a clinical trial with Israeli startup SpotitEarly, which is developing a cancer test that combines AI with trained dogs to analyze patients' breath. The study aims to validate this noninvasive approach alongside traditional screenings, potentially enabling earlier and more accessible cancer detection. Sponsored The Role of Claims Data Management to Support Evidence-Based Healthcare Presented by Veradigm Veradigm Senior Solutions Manager, Will Barnett talks about the health tech vendor's clearinghouse services and how they manage the relationship between payers and providers in support of evidence-based care and value-based care strategies. Learn more.

Featured News

Visana Health Secures $24M for Women's Health Clinic Visana Health's Series A round was led by Noro-Moseley Partners and included participation from The Cigna Group Ventures, Intermountain Ventures, Flare Capital Partners and Frist Cressey Ventures. Novartis Nabs FDA Approval for First-of-Its-Kind Drug for Chronic Hives Novartis drug Rhapsido is now approved as a second-line treatment for chronic spontaneous urticaria, a rare inflammatory skin disease. Additional clinical trials are ongoing to support potential expansion of the twice-daily pill to other immunological disorders. Price Transparency Enforcement Is Still A Shared Responsibility Despite all the noise around the updates, there's one area that's been conspicuously absent this year: enforcement of patient estimate requirements.

Video   Beyond Traditional, Broken Health Models Daniel Karlin, chief medical officer of MindMed, spoke at DiMe's Healthcare 2030 Summit in Washington, D.C. His company is developing novel treatments for brain health disorders, with a focus on psychiatry, neurology and addiction. Karlin urged healthcare leaders to look beyond existing data and assumptions to create more meaningful, systemic improvements.

Sponsored The Top-Rated Assistive Devices for Children With Sensory Processing Disorders Presented by Enabling Devices The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. Learn More.

Resources

Debunked Episode 19: Turmoil at the CDC, Epic's AI Strategy The latest episode of the Debunked podcast explores an ongoing debate questioning the role of payers in healthcare transactions. It also highlights turmoil at the CDC. View Now

MedCity News • PO Box 901 • New York, NY unsubscribe